COLLABORATION AND LICENSE AGREEMENT by and between Jazz Pharmaceuticals Ireland Limited and Werewolf Therapeutics, Inc. Dated as of April 6, 2022Collaboration and License Agreement • May 10th, 2022 • Werewolf Therapeutics, Inc. • Pharmaceutical preparations • New York
This Collaboration and License Agreement (this “Agreement”) is entered into as of April 6, 2022 (the “Effective Date”), by and between Jazz Pharmaceuticals Ireland Limited, a corporation organized under the laws of Ireland with its principal place of business at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland (“Jazz”), and Werewolf Therapeutics, Inc., a corporation organized under the laws of the State of Delaware with its principal place of business at 1030 Massachusetts Avenue, Suite 210, Cambridge, MA 02138 (“Werewolf”). Jazz and Werewolf are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
